Hong Kong stocks followed the downward trend of external and A-share markets.$恒生指數(800000.HK)$tumbled 351 points or 2.1% to close at 16,248.$國企指數(800100.HK)$decreased 112 points or 1.9% to close at 5,743.$恒生科技指數(800700.HK)$plummeted 104 points or 3% to close at 3,337. Total turnover for the day was $114.58 billion. Technology stocks$騰訊控股(00700.HK)$lowered 0.9% to $301.8, while$阿里巴巴-SW(09988.HK)$...
Hong Kong stocks resumed trading after the Ching Ming Festival holiday, and the market was volatile Friday.$恒生指數(800000.HK)$decremented 1 point to close at 16,723.$國企指數(800100.HK)$reduced 11 points or 0.2% to close at 5,863.$恒生科技指數(800700.HK)$waned 9 points or 0.3% to close at 3,450. Total turnover for the day was $73.615 billion. On the tech front,$阿里巴巴-SW(09988.HK)$and$京東集團-SW(09618.HK)$dropped 0.4% and 1....
Hong Kong stocks entered the results peak season.$恒生指數(800000.HK)$opened 29 points or 0.2% higher at 16,559.$國企指數(800100.HK)$opened 13 points or 0.2% higher at 5,794.$恒生科技指數(800700.HK)$opened 10 points or 0.3% higher at 3,538. $小米集團-W(01810.HK)$'s 4Q23 adjusted net profit surged 2.36x, beating expectations, and its share price climbed 2.2% to $15.2.$平安好醫生(01833.HK)$narrowed its loss to RMB323 million in 2023, and its...
The company's recent 11% uptick may be positive, but declining revenues and lack of profitability are worrisome. Shareholders have faced a 12% annual loss over five years. The company's future performance is uncertain, investors should ensure they are buying a high quality business.
The Nasdaq fell on its first trading day of 2024, with$蘋果(AAPL.US)$, which was downgraded to "underweight" by Barclays with TP down to US$160, continuing to drop 3.6%. In addition,$納斯達克中國金龍指數(.HXC.US)$, which reflects the performance of Chinese ADRs, lost 3.5%. $恒生科技指數(800700.HK)$busted below the 20 and 10MAs to bottom at 3,627, and last at 3,630, down 2.3%.$恒生指數(800000.HK)$also miss...
Ping An Healthcare's high P/S ratio may not be justified given the current and expected revenue growth. Stockholders may need to reconsider as this growth level could eventually negatively affect the share price. A positive change is needed to validate the current P/S ratio.
The 22% annualized share price decline warns the risk related to investing in unprofitable companies. Due to the unattractiveness of past share price performance, investor sentiment towards the stock might be skeptical unless the business reverses its fortunes.
The route to profitability for Ping An Healthcare is feasible but relies heavily on the firm maintaining a 64% yearly growth rate. Their prudent capital management strategy, favoring equity funding over debt, is seen as lowering investment risk.
平安好醫生股票討論區
還是10倍股嗎?跌到一塊然後漲到十塊那就是十倍股
HSI Dives 351 pts at Close; Tech Stocks Retreat
Technology stocks $騰訊控股(00700.HK)$ lowered 0.9% to $301.8, while $阿里巴巴-SW(09988.HK)$...
HSI Decrements 1 pt; Techs dropped
On the tech front, $阿里巴巴-SW(09988.HK)$ and $京東集團-SW(09618.HK)$ dropped 0.4% and 1....
HSI Opens 29 pts Higher
$小米集團-W(01810.HK)$ 's 4Q23 adjusted net profit surged 2.36x, beating expectations, and its share price climbed 2.2% to $15.2. $平安好醫生(01833.HK)$ narrowed its loss to RMB323 million in 2023, and its...
HSTECH 2.3% Lower; TENCENT/ NTES Sturdy;JD HEALTH Dive 5%-6.5%
$恒生科技指數(800700.HK)$ busted below the 20 and 10MAs to bottom at 3,627, and last at 3,630, down 2.3%. $恒生指數(800000.HK)$ also miss...
暫無評論